We extract DNA from blood or saliva donated by our participants. The DNA is quality controlled, banked and then analysed to study genetic variation by genotyping. We also store plasma and serum from blood samples.
All samples are sent to the NIHR-funded National Biosample Centre (NBC) in Milton Keynes, for processing, storage and analysis. NBC provides a high-quality, high-capacity service for biomedical researchers.
If you would like to know if our samples are suitable for your study please submit a query to email@example.com.
Apply to access samples
Access to samples is granted in the same way as recall studies, please see the Apply for Recall page for more information on the application and submission procedure.
All DNA will be genotyped, currently using the UKBiobank v2.1 Axiom array. Imputation of the genotyping data will also be available. If this does not cover the variant(s) of research interest then a KASP assay (a PCR based assay for 1 SNP) can be arranged on a relevant selection of our holdings.
8,000 of our Rare Disease participants have whole genome sequencing (WGS) data available.
10,000 of our IBD participants have whole exome sequencing available.
Available sample lists
- more than 50 projects recruiting from a wide range of clinical specialities
- Inflammatory Bowel Disease (IBD)
- Immune-Mediated Inflammatory Diseases (IMID)
- Mental Health (GLAD and EDGI)
- Non-Alcoholic Fatty Liver Disease (NAFLD)
Healthy population (population controls)
These include INTERVAL, COMPARE and STRIDES blood donor studies
- from blood (Rare Disease, IBD, IMID, NAFLD and healthy population themes)
- from saliva (Mental Health theme and some healthy population participants)